In the United States, to opt for its COVID-19 vaccine, Pfizer calls on 12-15-year-olds.
Pfizer requested this Friday that the United States health authorities authorize the application of its vaccine against COVID-19 in adolescents between 12 and 15 years old. The order comes nine days after the drugmaker announced that the inoculant had shown 100 percent efficacy in this demographic.
In a joint statement with the German BioNtech, with which it produces the immunizer, it also indicated that "they plan to make similar requests to other regulatory authorities around the world in the coming days